Literature DB >> 196801

Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens II. Induction of ADCC by FC-FC receptor bridging.

M Jondal.   

Abstract

Four different methods to test antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus (EBV) determined antigens were analysed. It was found that optimal ADCC was obtained if viral antigens were present during the cytotoxicity reaction and that killing probably was mediated by EBV-related immune-complexes forming Fc-Fc receptor bridges between Fc receptor-bearing effector cells and Fc receptor-bearing target cells. Only lymphoid target cells with a high expression of Fc receptors were found to be susceptible in this particular system.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 196801      PMCID： PMC1541038     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


  17 in total

1.  Expression of Epstein-Barr-virus-associated membrane antigen in Raji cells superinfected with two different virus strains.

Authors:  G Dölken; G Klein
Journal:  Virology       Date:  1976-03       Impact factor: 3.616

2.  Difference in antibody induced redistribution of membrane IgM in EBV geonome free and EBV positive human lymphoid cells.

Authors:  E Yefenof; G Klein
Journal:  Exp Cell Res       Date:  1976-04       Impact factor: 3.905

3.  Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis.

Authors:  E Svedmyr; M Jondal
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

4.  "Protein A" from S. aureus. I. Pseudo-immune reaction with human gamma-globulin.

Authors:  A Forsgren; J Sjöquist
Journal:  J Immunol       Date:  1966-12       Impact factor: 5.422

5.  Cloning of immunoglobulin-producing human leukemic and lymphoma cells in long-term cultures.

Authors:  Y Hinuma; J T Grace
Journal:  Proc Soc Exp Biol Med       Date:  1967-01

6.  Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus.

Authors:  G Klein; L Dombos; B Gothoskar
Journal:  Int J Cancer       Date:  1972-07-15       Impact factor: 7.396

7.  Separation of cells according to surface antigens by the use of antibody-coated columns. Fractionation of cells carrying immunoglobulins and blood group antigen.

Authors:  H Wigzell; K G Sundqvist; T O Yoshida
Journal:  Scand J Immunol       Date:  1972       Impact factor: 3.487

8.  Surface markers on human B and T lymphocytes. VIII. Association between complement and Epstein-Barr virus receptors on human lymphoid cells.

Authors:  M Jondal; G Klein; M B Oldstone; V Bokish; E Yefenof
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

9.  Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis.

Authors:  M Jondal
Journal:  Clin Exp Immunol       Date:  1976-07       Impact factor: 4.330

10.  Interaction of aggregated -globulin with B lymphocytes.

Authors:  H B Dickler; H G Kunkel
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307
View more
  2 in total

1.  Anti-class II antibodies in AIDS patients and AIDS-risk groups.

Authors:  S de la Barrera; L Fainboim; S Lugo; G R Picchio; G R Muchinik; M M de Bracco
Journal:  Immunology       Date:  1987-12       Impact factor: 7.397

2.  Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens. III. Reactivity in sera from patients with Burkitt's lymphoma in relation to tumour development.

Authors:  M Jondal; P Gunven
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.